Product Detail

Current Location: Home> Cytokines & Growth Factors>Others>Y00801 Recombinant Human EGF
Y00801 Recombinant Human EGF

Synonym: EGF

Species: Human

Protein Accession: P01133

Purity: >95%

Endotoxin Level: <0.1 ng/μg

Biological Activity: Determined by the dose-dependent stimulation of the proliferation of EGF-responsive Balb/3T3 Cells

Expression System: E. coli

Fusion Tag: None

Predicted Molecular Mass: 6.2 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS

Reconstitution: Reconstitute in DMSO

Storage & Stability: Store at -20°C upon receipt, aliquot and store at -20°C or -80°C. Avoid repeated freeze-thaw cycles.

FAQ

What is Y00801 Recombinant Human EGF, and how does it benefit the feed industry?
Y00801 Recombinant Human Epidermal Growth Factor (EGF) is a biotechnologically produced protein that plays a crucial role in cell growth, proliferation, and differentiation. In the feed industry, it is primarily utilized to promote improved growth rates and overall health in livestock, poultry, and aquaculture. The benefits stem from EGF's ability to enhance nutrient absorption, reinforce intestinal health, and mitigate the effects of stress and disease. When introduced to animal feed, Y00801 stimulates the growth and repair of epithelial tissues, leading to better nutrient uptake and energy efficiency. This results in faster growth rates, higher feed conversion ratios, and ultimately, increased productivity. Additionally, the consistent use of EGF can reduce the need for antibiotics, thereby promoting a more sustainable and eco-friendly farming practice.

How can Y00801 Recombinant Human EGF improve feed conversion ratios in livestock?
EGF enhances feed conversion ratios (FCR) by promoting the health and functionality of the gastrointestinal tract. When the epithelial cells lining the gut are healthy and rapidly regenerating, the animal can absorb nutrients more efficiently. This means that more of the feed is converted into usable energy and growth rather than being wasted. EGF's impact on cellular proliferation helps in maintaining optimal gut health, reducing lesions, and fighting off pathogenic attacks, which commonly hinder nutrient absorption. By ensuring a well-maintained gut lining, Y00801 minimizes nutrient loss and maximizes feed efficiency, thereby improving overall FCR. This translates to reduced feed costs and better growth performance, making livestock production more cost-effective and efficient.

Are there any specific animals that benefit more from Y00801 Recombinant Human EGF supplementation?
While Y00801 has shown positive effects across various species, certain animals may exhibit more pronounced benefits due to their unique physiology and growth patterns. In broiler chickens, for instance, EGF supplementation can significantly shorten the growth cycle, allowing for quicker turnover and higher yield. In swine, especially during weaning periods, the introduction of EGF can mitigate the stress-related reduction in growth rates. Aqua-farming species, like fish and shrimp, also greatly benefit from EGF as it improves their ability to fight off common diseases and enhances overall growth rates. Dairy cattle can see improvements in milk production and quality due to better nutrient uptake and overall health. Therefore, while beneficial to a wide range of animals, the most noteworthy impacts are observed in rapidly growing and high-stress species like poultry, swine, and aquaculture.

What dosage of Y00801 Recombinant Human EGF is recommended for optimal results?
The optimal dosage of Y00801 Recombinant Human EGF varies depending on the species, age, and specific needs of the animals being fed. For poultry, recommended dosages usually range between 0.1 to 0.3 mg/kg of feed. In swine, particularly during the weaning phase, dosages may be slightly higher, around 0.2 to 0.5 mg/kg of feed. For aquaculture, the dosages also fall within a similar range, generally between 0.1 to 0.4 mg/kg of feed. It's important to conduct controlled trials and monitor animal response to fine-tune the dosage according to specific requirements. Over-supplementation can lead to diminishing returns or potential negative effects, so adherence to recommended guidelines and close observation is crucial. Consulting with a veterinary nutritionist can provide more precise dosage tailored to specific livestock conditions and objectives.

Are there any side effects or considerations when using Y00801 Recombinant Human EGF in animal feed?
Generally, Y00801 Recombinant Human EGF is considered safe when used at recommended dosages, but like any feed additive, it is important to observe the animals for any adverse reactions when introducing it for the first time. In rare cases, over-supplementation can lead to hyper-proliferation of cells, which might cause gut imbalances or unexpected growth anomalies. It is also crucial to maintain a balanced diet; EGF should not replace essential nutrients but rather complement them to enhance overall growth and health. Regular monitoring and consultation with veterinary professionals can ensure that the supplementation is done correctly and adjustments are made as necessary. Since this is a novel supplement, it’s advisable to stay updated with ongoing research and field studies that might provide new insights into its long-term effects and optimal usage strategies.

Jiangsu East-Mab Biomedical Technology Co.,Ltd

contact us

Factory address:
Life and Health Industrial Park, Rudong County, Nantong City, Jiangsu Province

Contact: Fred Wang
Tel: 0086-25-52397805
Phone/WhatsApp: 0086-18005193850

mobile
Jiangsu East-Mab Biomedical Technology Co.,Ltd

Copyright(C)2023,Jiangsu East-Mab Biomedical Technology Co.,Ltd All Rights Reserved.

Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.